Direct ‐to‐consumer genetic testing for factor V Leiden and prothrombin 20210G > A: the consumer experience

ConclusionConsumers reported moderate rates of behavioral change and perceived personal benefit from receiving DTC genetic results for VTE risk.

Source: Molecular Genetics & Genomic Medicine - September 15, 2020 Category: Genetics & Stem Cells Authors: Sarah L. Elson, Nicholas A. Furlotte, Bethann S. Hromatka, Catherine H. Wilson, Joanna L. Mountain, Helen M. Rowbotham, Elizabeth A. Varga, Uta Francke Tags: ORIGINAL ARTICLE Source Type: research